RecruitingPhase 2NCT07187531
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Sponsor: SAb Biotherapeutics, Inc.
Dallas, TX · Fort Worth, TX · Houston, TX · +19 more sites
3 recruiting type 1 diabetes studies with a site in Fort Worth, TX.
Sponsor: SAb Biotherapeutics, Inc.
Dallas, TX · Fort Worth, TX · Houston, TX · +19 more sites
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · Conroe, TX · +106 more sites
Sponsor: Sanofi
Austin, TX · Dallas, TX · Fort Worth, TX · +34 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.